- For Individuals and Families
- For Businesses and Employers
- For Our Clients
- For Individuals (Personal Insurance)
- For Employees (Group Insurance)
- For Our Partners
- Resource Centre
- Contact Us
NUH Main Building Zone F
National University Heart Centre
NUH Main Building Zone F
5 Lower Kent Ridge Road Singapore 119074 | Opening Hours
Mon – Fri: 8:30am to 5:30pm. Sat, Sun & PH: Closed
Assistant Professor Chester Drum, M.D. Ph.D., is an assistant professor at the National University of Singapore, a consultant cardiologist at the National University Hospital and director of the Clinical Trial Innovation Lab at TLGM, A*STAR. He is a Singapore permanent resident and currently maintains both internal medicine and cardiology board certifications in the US and Singapore. Asst. Prof. Drum received an M.D. and Ph.D. from the University of Chicago. He was trained in internal medicine at the University of California, San Diego and as a cardiologist at the Brigham and Women’s Hospital (Harvard Medical School) in Boston. After receiving the Burroughs Wellcome Career Award for Medical Scientists, he then moved to Massachusetts Institute of Technology (MIT) where he was director of Translational Medicine for the regulatory innovation group, MIT-NEWDIGS. Asst. Prof. Drum has over 20 years of clinical experience in managed care, private, public and academic healthcare settings and holds multiple patents. In 2011, he was recruited to the National University of Singapore and has since received funding from the Singapore MIT Alliance for Research and Technology, National Medical Research Council, Biomedical Research Council, A*STAR and the Yong Loo Lin School of Medicine at the National University of Singapore.
Asst. Prof. Drum’s current research bridges the gap between basic biochemistry and clinical care. Using fundamental concepts in biochemistry and synthetic biology, the lab creates therapeutics for unmet clinical needs. Biochemical investigations of human cohorts often leverage mass spectroscopy to answer fundamental questions of disease mechanism and prognosis. Asst. Prof. Drum is currently the primary investigator on a multi-institutional, 3,000 person observational trial in Singapore which studies how personalized drug metabolism effects drug response. Recent publications include contributions to the journals Nature Communications, Journal of the American Heart Association, PNAS and Small in addition to featured editorial content in Science Translational Medicine.
MD (USA), PhD (USA)